NYXH Nyxoah

Conditional Issuance of Shares

Conditional Issuance of Shares

INSIDE INFORMATION

REGULATED INFORMATION

Conditional Issuance of Shares

Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), today announced a conditional issuance of up to 5 million ordinary shares under its existing at-the-market equity offering programs (the “ATM”). This brings the aggregate number of ordinary shares that can be sold and issued under the Company’s ATM to 5,662,694 (the “ATM Shares”), which includes 662,694 shares that are still available from the conditional issuance of shares under the ATM decided upon on December 22, 2022.

Pursuant to the existing sales agreement entered into by the Company on December 22, 2022, ATM Shares may be sold from time to time at a sales price per ATM Share equal to prevailing USD market prices of the Nyxoah ordinary share on the Nasdaq Global Market at the time of the sale.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities.

Contacts:

Nyxoah

John Landry, CFO



Attachment



EN
16/04/2025

Underlying

NYXHNyxoah

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE
Free
NYXH NYXOAH

Nyxoah Reports First Quarter Financial and Operating Results

Nyxoah Reports First Quarter Financial and Operating Results REGULATED INFORMATION Nyxoah Reports First Quarter Financial and Operating Results Company On Track for Anticipated PMA Approval in the Second Quarter of 2025 Successfully Completed FDA Validation Requirements, Final Site Inspection in Progress Mont-Saint-Guibert, Belgium – May 14, 2025, 7am CET / 1am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported f...

May 14, 2025 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Nyxoah Présente ses Résultats Financiers et Opérationnels du Premier T...

Nyxoah Présente ses Résultats Financiers et Opérationnels du Premier Trimestre INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et Opérationnels du Premier Trimestre La Société est en bonne voie pour obtenir l'autorisation de mise sur le marché au deuxième trimestre 2025 Les exigences de validation de la FDA ont été remplies avec succès, l'inspection finale du site est en cours Mont-Saint-Guibert, Belgique – 14 mai 2025, 07h00 CET / 01h00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des al...

May 14, 2025 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 9, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. FMR LLC On May 2, 2025, Nyxoah received a transparency notification from FMR LLC. Based on the notification, FMR LLC (together with its controlled undertakings) holds...

May 9, 2025 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence          INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 9 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu une notification de transparence comme détaillé ci-dessous. FMR LLC Le 2 mai 2025, Nyxoah a reçu une notification de transparence de FMR LLC. Sur la base de la notification, FMR LLC (avec ses entrepr...

May 9, 2025 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Invitation to attend the annual and the extraordinary shareholders’ me...

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 REGULATED INFORMATIONMay 9, 2025, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders' meeting of the Company, to be held on Wednesday, June 11, 2025 ...

May 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch